Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-10-07Clinical Trial Update: Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy [NA]
This entry reports a clinical trial investigating whether normobaric hyperoxygenation can prevent contrast-induced nephropathy; current stat…
-
CLINICAL_TRIALS research · 2011-08-03Clinical Trial Update: Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
A clinical trial update on the relationship between contrast medium volume and the risk of contrast-induced nephropathy following percutaneo…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy [NA]
A completed clinical trial from Huashan Hospital evaluating whether genetic polymorphisms in oxidative stress pathways influence contrast-in…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Prevention of Contrast-Induced Nephropathy [NA]
This entry notes the completed clinical trial evaluating prevention of contrast-induced nephropathy sponsored by the University of Alberta.
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Bicarbonate v Saline to Prevent Contrast Nephropathy [Phase 4]
Phase 4 trial comparing bicarbonate versus saline to prevent contrast-induced nephropathy was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 4]
A Phase 4 clinical trial comparing iso-osmolar iodixanol with low-osmolar iohexol contrast agents in acute myocardial infarction patients un…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Sodium Bicarbonate in Preventing Contrast Induced Nephropathy [NA]
Clinical trial update on using sodium bicarbonate to prevent contrast-induced nephropathy; the study status is completed.
-
CLINICAL_TRIALS research · 2010-07-27Clinical Trial Update: NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED [Phase 4]
A Phase 4 trial at Seoul National University Hospital is evaluating whether N-acetylcysteine can prevent contrast-induced nephropathy in pat…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection [Phase 4]
A Phase 4 trial assessed whether a sodium bicarbonate bolus can prevent contrast-induced nephropathy in patients undergoing emergent coronar…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine [NA]
Clinical trial comparing sodium bicarbonate to sodium chloride and N-acetylcysteine for preventing contrast-induced nephropathy has complete…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients [Phase 3]
Phase 3 clinical trial evaluating whether alpha tocopherol can prevent contrast-induced nephropathy in patients with chronic kidney disease;…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy
This completed clinical trial evaluates neutrophil gelatinase-associated lipocalin (NGAL) as a blood marker to assess the risk of contrast-i…
-
CLINICAL_TRIALS research · 2009-11-23Clinical Trial Update: Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients [EARLY_Phase 1]
An early-phase 1 study in ICU patients is investigating contrast agent–associated nephrotoxicity. The trial status is UNKNOWN and the sponso…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention [Phase 3]
Phase 3 clinical trial comparing induced diuresis with matched hydration versus standard hydration for prevention of contrast-induced nephro…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy [Phase 4]
Phase 4 trial evaluating intravenous Acetadote (N-acetylcysteine) for prevention of contrast-induced nephropathy. The update does not provid…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography [Phase 4]
Phase 4 clinical trial update evaluating prevention of contrast-induced nephropathy in diabetic patients undergoing coronary angiography.
-
CLINICAL_TRIALS trial_result · 2009-04-06Clinical Trial Update: Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial [Phase 4]
A Phase 4 trial (ERIN) evaluating erythropoietin for prevention of contrast-induced nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy [NA]
A clinical trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography [Phase 2, Phase 3]
This clinical trial update concerns using N-acetylcysteine to prevent contrast-induced nephropathy in critically ill patients undergoing con…
-
CLINICAL_TRIALS trial_result · 2008-12-16Clinical Trial Update: Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease [Phase 3]
A Phase 3 clinical trial evaluating whether N-acetylcysteine can prevent contrast-induced nephropathy after catheterization in diabetic pati…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN [Phase 2]
Phase 2 trial update on preventing contrast-induced nephropathy with sodium bicarbonate in high-risk patients with pulmonary edema, heart fa…
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN) [Phase 3]
Phase 3 trial evaluating whether sodium bicarbonate solution lowers the incidence of contrast-induced nephropathy. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: COOL RCN: Cooling to Prevent Radiocontrast Nephropathy [Phase 2, Phase 3]
The COOL RCN trial evaluating cooling to prevent radiocontrast nephropathy in Phase 2 and Phase 3 was terminated.
-
CLINICAL_TRIALS trial_result · 2008-05-08Clinical Trial Update: Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients
Completed clinical trial evaluating whether cystatin C can serve as an early biomarker of contrast-induced nephropathy in patients undergoin…
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy [Phase 2]
A Phase 2 trial comparing acetazolamide versus sodium bicarbonate for prevention of contrast-induced nephropathy has completed.